FGFR3 and achondroplasia: In 2014, intraperitoneally injected statins rescued long bone growth in a mouse model of achondroplasia Fgfr3Ach [43] but a later study demonstrated that statins do not inhibit FGFR3 signalling in chondrocytes [44].